Post Categories
RNA Editing: A Safer Alternative in Genetic Medicine?
June 17, 2024
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated…
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
June 10, 2024
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to…
Understanding the Rise in Cancer Rates Among Young Adults
May 13, 2024
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the…
Oncology Clinical Trials: Understanding Industry Challenges
May 8, 2024
In 2024, roughly 2 million people in the United States will be diagnosed with cancer, per the National Cancer Institute. Given that stark statistic,…
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine…
The Future of Oncology Treatment
May 1, 2024
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements…
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in…
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
Less Sitting, More Living: How Activity Reduces Risk for Heart Attack Survivors
June 24, 2025
Sitting down might seem harmless, but for heart attack survivors, prolonged sedentary time could spell significant trouble. According to recent research, replacing just 30…
Sight Concerns: Investigating the Link Between GLP-1 RA Medications and Eye Health
June 16, 2025
Glucagon-like peptide (GLP-1) receptor agonists (GLP-1 RAs) are transformative medications for millions of people managing diabetes and obesity. Amid research demonstrating the many benefits…
Non-Opioid Painkiller Blocks Pain at Its Source
June 11, 2025
Synthetic and semi-synthetic opioids offer powerful pain relief. Unfortunately, these drugs are also associated with negative outcomes, including addiction and overdose. The U.S. Centers…
Injecting Hope: Early Steps Toward Prenatal Treatment for Genetic Disorders
June 9, 2025
The potential to treat severe genetic disorders before birth has taken a promising step forward. Researchers at the University of California, San Francisco (UCSF)…
Unanswered Questions: Mysterious Cluster of Brain Tumors Investigated at Massachusetts Hospital
June 2, 2025
Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital in Massachusetts have been diagnosed with benign brain tumors, sparking concern about a…
Creutzfeldt-Jakob Disease Outbreak Sparks Concern
May 21, 2025
Prion diseases are rapidly progressive, neurodegenerative disorders caused by infectious protein particles called prions. While these diseases can affect both humans and animals, they…
Introduction Antiviral drugs play a central role in treating viral infections, reducing disease progression and preparing for future outbreaks. While vaccines can help prevent…
Executive Summary The boundary between pharmacovigilance and regulatory affairs has never been thinner. As health authorities accelerate the digitization of safety reporting, tighten electronic…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
GRONINGEN, Netherlands–(BUSINESS WIRE)–QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…